Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 5 | 2023 | 1547 | 1.000 |
Why?
|
| Genome-Wide Association Study | 6 | 2025 | 1842 | 0.820 |
Why?
|
| Multifactorial Inheritance | 2 | 2021 | 173 | 0.790 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 341 | 0.610 |
Why?
|
| Tissue Donors | 1 | 2023 | 504 | 0.600 |
Why?
|
| Machine Learning | 1 | 2023 | 386 | 0.580 |
Why?
|
| Surgeons | 1 | 2022 | 289 | 0.520 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2025 | 3428 | 0.380 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2025 | 2849 | 0.300 |
Why?
|
| Linkage Disequilibrium | 3 | 2024 | 319 | 0.250 |
Why?
|
| United Kingdom | 2 | 2024 | 257 | 0.220 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2025 | 326 | 0.200 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2023 | 99 | 0.200 |
Why?
|
| Population Health | 1 | 2023 | 35 | 0.190 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2025 | 227 | 0.180 |
Why?
|
| Industry | 1 | 2022 | 28 | 0.180 |
Why?
|
| Workplace | 1 | 2023 | 83 | 0.180 |
Why?
|
| Failure to Rescue, Health Care | 1 | 2021 | 11 | 0.180 |
Why?
|
| International Agencies | 1 | 2021 | 28 | 0.180 |
Why?
|
| Smoking | 2 | 2024 | 923 | 0.180 |
Why?
|
| Risk | 1 | 2023 | 729 | 0.170 |
Why?
|
| Quarantine | 1 | 2021 | 17 | 0.170 |
Why?
|
| Bayes Theorem | 1 | 2023 | 308 | 0.170 |
Why?
|
| Conflict of Interest | 1 | 2022 | 65 | 0.170 |
Why?
|
| Crohn Disease | 1 | 2024 | 292 | 0.170 |
Why?
|
| Education | 1 | 2021 | 111 | 0.170 |
Why?
|
| Humans | 18 | 2025 | 130854 | 0.170 |
Why?
|
| Abdominal Injuries | 1 | 2022 | 119 | 0.160 |
Why?
|
| Erythrocyte Transfusion | 1 | 2022 | 142 | 0.160 |
Why?
|
| Thymidine Phosphorylase | 1 | 2020 | 11 | 0.160 |
Why?
|
| Neurofibromatoses | 1 | 2020 | 9 | 0.160 |
Why?
|
| Mitochondrial Encephalomyopathies | 1 | 2020 | 27 | 0.160 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2022 | 215 | 0.150 |
Why?
|
| Blood Transfusion | 1 | 2022 | 291 | 0.150 |
Why?
|
| Neurilemmoma | 1 | 2020 | 41 | 0.150 |
Why?
|
| Alcohol Drinking | 1 | 2021 | 344 | 0.140 |
Why?
|
| Databases, Genetic | 1 | 2021 | 507 | 0.140 |
Why?
|
| Hockey | 1 | 2018 | 3 | 0.140 |
Why?
|
| Athletic Performance | 1 | 2018 | 14 | 0.140 |
Why?
|
| Logistic Models | 1 | 2023 | 1805 | 0.140 |
Why?
|
| Case-Control Studies | 2 | 2023 | 3393 | 0.130 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2022 | 401 | 0.130 |
Why?
|
| Databases, Factual | 1 | 2022 | 1228 | 0.130 |
Why?
|
| Brain Concussion | 1 | 2018 | 249 | 0.110 |
Why?
|
| Phenotype | 2 | 2024 | 4482 | 0.110 |
Why?
|
| Body Mass Index | 1 | 2021 | 1681 | 0.110 |
Why?
|
| Age Factors | 1 | 2021 | 2841 | 0.110 |
Why?
|
| Mitochondria | 1 | 2020 | 775 | 0.110 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 901 | 0.090 |
Why?
|
| Liver Transplantation | 1 | 2020 | 1138 | 0.080 |
Why?
|
| United States | 2 | 2023 | 11865 | 0.080 |
Why?
|
| Retrospective Studies | 5 | 2022 | 17673 | 0.060 |
Why?
|
| Infant, Newborn | 3 | 2022 | 8509 | 0.050 |
Why?
|
| Sildenafil Citrate | 1 | 2022 | 56 | 0.050 |
Why?
|
| Colitis, Ulcerative | 1 | 2024 | 215 | 0.040 |
Why?
|
| Injury Severity Score | 1 | 2022 | 233 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2022 | 6448 | 0.040 |
Why?
|
| Quantitative Trait Loci | 1 | 2022 | 308 | 0.040 |
Why?
|
| Trauma Centers | 1 | 2022 | 205 | 0.040 |
Why?
|
| Thymidine | 1 | 2020 | 49 | 0.040 |
Why?
|
| Esophageal Motility Disorders | 1 | 2020 | 19 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2022 | 466 | 0.040 |
Why?
|
| Postoperative Complications | 2 | 2022 | 3130 | 0.040 |
Why?
|
| Hand | 1 | 2020 | 95 | 0.040 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2020 | 132 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2022 | 542 | 0.030 |
Why?
|
| Comorbidity | 1 | 2023 | 1587 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2021 | 678 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2021 | 343 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2022 | 522 | 0.030 |
Why?
|
| Risk Factors | 2 | 2023 | 10978 | 0.030 |
Why?
|
| Child | 3 | 2022 | 26215 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2021 | 1066 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2021 | 699 | 0.030 |
Why?
|
| Infant | 2 | 2021 | 13299 | 0.030 |
Why?
|
| Liver | 1 | 2022 | 1799 | 0.030 |
Why?
|
| Male | 4 | 2025 | 64763 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 3807 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 1977 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2022 | 3694 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 5095 | 0.020 |
Why?
|
| Female | 3 | 2025 | 70550 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 1264 | 0.020 |
Why?
|
| Pregnancy | 1 | 2022 | 7402 | 0.020 |
Why?
|
| Adult | 2 | 2020 | 31238 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 3827 | 0.020 |
Why?
|
| Adolescent | 1 | 2020 | 20818 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 28511 | 0.010 |
Why?
|